Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model - Summary - MDSpire
Advertisement
Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model
To identify systemic circulating biomarkers associated with vascular dementia (VaD) risk and investigate corresponding neuropathological mitochondrial changes in the brain.
Approach:
Mendelian Randomization Analysis: Two-sample MR analysis of plasma proteomics and GWAS data to identify candidate proteins associated with VaD risk.
Transcriptomic Analysis: Assessment of differential expression of candidate genes using the GEO dataset GSE122063.
In Vivo Validation: Validation of proteins in a Bilateral Common Carotid Artery Occlusion (2-VO) rat model through evaluation of pathological features and protein expression levels.
The study identifies COX5B as a potential target for further investigation into its role in VaD, while also noting the complexities surrounding AIFM1, NDUFV2, and NUDT5.